Change - Announcement Of Cessation :: Cessation Of Chief Executive Officer (China)
BackOct 16, 2017
| Announcement Title | Change - Announcement of Cessation |
| Date & Time of Broadcast | Oct 16, 2017 17:42 |
| Status | New |
| Announcement Sub Title | Cessation of Chief Executive Officer (China) |
| Announcement Reference | SG171016OTHR6TDO |
| Submitted By (Co./ Ind. Name) | Andrew Young |
| Designation | Senior Legal Counsel |
| Description (Please provide a detailed description of the event in the box below) | Cessation of Dr Cheah Kim Fee ("Dr Cheah") as Chief Executive Officer (China). |
| Additional Details | |
| Name Of Person | Cheah Kim Fee |
| Age | 51 |
| Is effective date of cessation known? | Yes |
| If yes, please provide the date | 12/10/2017 |
| Detailed Reason (s) for cessation | Personal reason to pursue other interests. |
| Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
| Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
| Any other relevant information to be provided to shareholders of the listed issuer? | No |
| Date of Appointment to current position | 30/03/2017 |
| Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
| Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 2 |
| Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 1 |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Chief Executive Officer (China) |
| Role and responsibilities | Dr Cheah's role was to identify and assess strategic merger and acquisition opportunities in the China South dental healthcare industry. He was also tasked with initiating preliminary negotiations with companies that fit the Group's investment criteria, post-acquisition integration. |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | NIL |
| Shareholding interest in the listed issuer and its subsidiaries? | Yes |
| Shareholding Details | Q & M Aidite International Pte. Ltd.: 210,936 non-voting, redeemable and non-convertible class A preference shares Aoxin Q & M Dental Group Limited: 641,026 shares |
| Past (for the last 5 years) | - Q & M Dental (Beijing) Pte. Ltd. (liquidated) - Qinhuangdao Aidite High Technical Ceramics Co (restructured) - Shanghai Q&M Investment Management Consulting Co - Shenyang XinAo Hospital Management Co - Shenyang Quanxin Medical Leasing Co - Q & M Dental (Shanghai) Pte. Ltd. - Shenyang Q&M Management Consulting Co - AR Dental Supplies Sdn Bhd - Q & M Dental Holdings (Shenzhen) Pte. Ltd. - Q & M Dental Laboratory (Zhejiang) Pte. Ltd. (struck off) |
| Present | - Shanghai Chuangyi Investment Management Co - Aidite (Qinhuangdao) Technology Co Ltd |